CannaStrips will generate near-term revenue, while the company’s blue-sky pharmaceutical assets and orphan drug are solid, long-term plays
Showing 25 of 117
The firm's current B-cell laboratory in British Columbia is operating at full capacity..
Clinicians will be using the firm's tech to analyze poor quality ultrasound images.
The SEC and FINRA have approved acquisitions that will allow the exchange to operate as a broker-dealer
Analyst Greg McLeish says the investment thesis remains intact and keeps a C$4 target price on the stock
The company says it has a strong balance sheet and is committed to its expanding medical business as well as capitalizing on the upcoming adult-use market in Canada
Larssen has been involved with over 1,000 projects around the globe, said High Hampton
Serial entrepreneur Lorne Gertner has become a strategic consultant to the company, it said
The firm will supply the Canadian province with branded cannabis products for sale in the adult-use market
The company also announced it has appointed a new chief executive officer, Keith Merker, who was previously the chief financial officer.
The biotech will use social media and influencers to promote its fertility-enhancing gel
Canntab will build, at its own expense, its own manufacturing facility to produce cannabis oral dose delivery platforms
As part of the acquisition, High Hampton gains control of a strategic distribution hub in Sacramento..
It will supply the province with branded cannabis products for sale in Alberta’s adult-use market
The funds were earmarked for research and development (R&D) programmes and for general working capital purposes
WeedMD has partnered with Revive Therapeutics in looking at ways to treat liver disease using cannabidiol (CBD).
The analysts viewed the Canadian company’s VersaFilm oral film drug delivery platform as 'disruptive' for the pharma industry
More spending in the quarter deepened the net loss but saw a pickup in revenue
The relationship with LifeStyles positions Callitas products further into the sexual wellness space
The company said the engagement will augment the company's effort to obtain government authorization for production of omega-3 products at its Canadian manufacturing facility.
The company said the plants were transplanted last week to its Strathroy greenhouse in Ontario and are scheduled to be harvested by September 2018.
Canada is first major economy to vote to legalize recreational cannabis use and according to industry analysts, the Canadian cannabis industry could surpass C$22 billion in size over the coming years.
Biolog has developed a patented system to infuse food and beverages with cannabis
Job creation is booming as the cannabis industry looks to fill a wide array of roles – some paying more than six figures
420 will manufacture, deliver, and distribute various flower strains and cannabis concentrates